Clinical Trials Directory

Trials / Completed

CompletedNCT02562170

Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Randomized controlled trial to look at early complications, cosmetic outcome, patient satisfaction and thickness of the tissue overlying the implant at the lower pole in immediate implant based breast reconstruction after Skin or Nipple Sparing Mastectomy with either a mesh (TiLOOP Bra) or an ADM (Protexa). Multicenter austrian trial with four breast cancer centers, 50 patients randomized 1:1 in the TiLoop or Protexa group.

Conditions

Interventions

TypeNameDescription
DEVICETiLoop Bra
DEVICEProtexa

Timeline

Start date
2013-07-01
Primary completion
2015-04-01
Completion
2015-05-01
First posted
2015-09-29
Last updated
2015-09-29

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02562170. Inclusion in this directory is not an endorsement.